Straub T, Reynaud M, Yaron M. [Intrauterine device and pelvic inflammatory disease: Myth or reality?].
ACTA ACUST UNITED AC 2018;
46:414-418. [PMID:
29627410 DOI:
10.1016/j.gofs.2018.03.002]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2017] [Indexed: 11/30/2022]
Abstract
INTRODUCTION
Intrauterine device (IUD) is a reliable contraceptive method that is long term reversible, and well tolerated. Numerous studies prove its efficiency and report rare complications that are attributed to it. However, its use is limited due to fear that it can cause a pelvic inflammatory disease (PID). This is based on historical data on infections related to the "Dalkon Shield", which was removed from the market in 1974.
METHOD
The analyzed articles were extracted from PUBMED database between 2000 and 2016. In total, 22 studies were retained. A meta-analysis was not possible due to the methodological diversity among the selected articles contributing to this narrative review of the literature.
RESULTS
After analysis, the following factors influence the risk of PID linked to IUDs: an advanced age and sexually transmitted infections.
CONCLUSION
The risk of PID linked to IUDs is lower than 1%. This is explained by new models of IUD, better screening tests, more frequent follow-up of the patients and the improvement of care PID patients. In the light of our results, the threat of pelvic inflammatory disease should not hinder the use of IUDs.
Collapse